These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7749977)

  • 1. Suppression of the skin reaction to histamine by ebastine.
    Nelson HS; Bucher B; Buchmeier A; Oppenheimer J; Garcia J
    Ann Allergy Asthma Immunol; 1995 May; 74(5):442-7. PubMed ID: 7749977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistency of the efficacy of cetirizine and ebastine on skin reactivity.
    Frossard N; Melac M; Benabdesselam O; Pauli G
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):61-5. PubMed ID: 9475569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
    Antonijoan RM; García-Gea C; Puntes M; Valle M; Esbri R; Fortea J; Barbanoj MJ
    Clin Drug Investig; 2007; 27(7):453-61. PubMed ID: 17563125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
    Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers.
    Frossard N; Benabdesselam O; Purohit A; Mounedji N; Pauli G
    Fundam Clin Pharmacol; 2000; 14(4):409-13. PubMed ID: 11030449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebastine in perennial allergic rhinitis.
    Picado Vallés C; Cadahia García A; Cisteró Bahima A; Cano Cantudo L; Sanz Amaro A; Zayas Sanza JM
    Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg.
    Magerl M; Schmolke J; Metz M; Zuberbier T; Siebenhaar F; Maurer M
    Clin Exp Dermatol; 2009 Jul; 34(5):e137-40. PubMed ID: 19323664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired cold urticaria symptoms can be safely prevented by ebastine.
    Magerl M; Schmolke J; Siebenhaar F; Zuberbier T; Metz M; Maurer M
    Allergy; 2007 Dec; 62(12):1465-8. PubMed ID: 17900265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
    Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Itraconazole and rifampin alter significantly the disposition and antihistamine effect of ebastine and its metabolites in healthy participants.
    Shon JH; Yeo CW; Liu KH; Lee SS; Cha IJ; Shin JG
    J Clin Pharmacol; 2010 Feb; 50(2):195-204. PubMed ID: 19841159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ebastine : treatment of perennial rhinitis in the child].
    Benavente V; Eseverri JL; Botey J; Marin A
    Allerg Immunol (Paris); 1996 Oct; 28(8):277-81. PubMed ID: 9011166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative clinical studies with ebastine: efficacy and tolerability.
    Luria X
    Drug Saf; 1999; 21 Suppl 1():63-7; discussion 81-7. PubMed ID: 10597869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity.
    Purohit A; Duvernelle C; Melac M; Benabdesselam O; Pauli G; Frossard N
    Eur J Clin Pharmacol; 1999 Oct; 55(8):589-92. PubMed ID: 10541777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR; Faulds D
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of inhibition of wheal response to histamine by multiple doses of terfenadine.
    Ryan WM
    Ann Allergy; 1989 Dec; 63(6 Pt 2):609-11. PubMed ID: 2574553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
    Antépara I; Jaúregui I; Basomba A; Cadahia A; Feo F; García JJ; Gonzalo MA; Luna I; Rubio M; Vázquez M
    Allergol Immunopathol (Madr); 1998; 26(1):9-16. PubMed ID: 9585822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
    Carey W; Warrington S; Boyce M; Luria X
    Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity.
    Barbanoj MJ; Antonijoan RM; García-Gea C; Morte A; Gich I; Gispert J; Garcia E; Esbrí R; Luria X
    Int Arch Allergy Immunol; 2003 Nov; 132(3):263-7. PubMed ID: 14646388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.